Important Update on Robitussin Class Action Settlement Notice
Overview of the Robitussin Class Action Settlement
If you purchased certain Robitussin products during the designated class period, you may qualify for compensation as part of a class action settlement involving GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, now known as Haleon US Holdings LLC.
Key Details About the Settlement
This settlement addresses allegations made by plaintiffs Nancy Galchi and Stacey Papalia, who claim that Haleon incorrectly marketed specific Robitussin products as 'Non-Drowsy' despite their ingredients, including dextromethorphan (DXM), which can induce drowsiness.
Monetary and Injunctive Relief
The total settlement amount is set at $4.5 million, which is allocated towards various purposes:
- Monetary benefits to eligible class members.
- Administration expenses capped at $550,000.
- Attorneys' fees approved by the court, not exceeding one-third of the Gross Settlement Fund, amounting to $1.5 million.
- Class representative service awards of $2,000 each.
Additionally, Haleon has agreed to stop marketing the covered products with claims of being 'Non-Drowsy' and will exclude this label from any future promotion and advertising.
Who is Eligible for Compensation?
To qualify for a payment, individuals must have purchased any flavor of Robitussin products containing DXM that were marketed as 'non-drowsy.' Purchases should have been made for personal use and must fall within the specified class period.
How to Claim Your Payment
To receive your share of the settlement, it is imperative to complete and submit a valid Claim Form in a timely manner. These forms can be acquired through the settlement website or by contacting the Settlement Administrator directly.
Submission Guidelines
The completed Claim Form must either be submitted online or postmarked by the designated deadline.
The mailing address for submissions is as follows:
Robitussin Settlement
c/o Settlement Administrator
1650 Arch Street, Suite 2210
Philadelphia, PA 19103
Your Rights in the Settlement
If you opt not to participate or fail to submit a valid claim, you will still be bound by the terms of the settlement. Alternatively, if you wish to preserve your rights to pursue a separate lawsuit against Haleon, you must formally exclude yourself from the settlement by the specified date.
Understanding the Court Hearing
A Final Approval Hearing is scheduled, during which the court will assess the fairness and adequacy of the proposed settlement. Participation in this hearing allows for objections to be raised regarding the settlement.
Keep yourself updated by checking the settlement website for any possible changes to the hearing date or format, whether in person or via video.
Frequently Asked Questions
What is the purpose of the class action settlement?
The class action settlement aims to address allegations of misleading marketing regarding Robitussin products that contain DXM.
How can I find if I am eligible for compensation?
You may be eligible if you've purchased specific Robitussin products marketed as 'Non-Drowsy' during the class period.
What steps must I take to file a claim?
To file a claim, you must obtain and submit a completed Claim Form either online or through mail by the cut-off date.
What happens if I do not submit my claim?
If you do not submit a valid claim, you will not receive any payment but will still be bound by the settlement terms.
Where can I get more updates on the settlement?
Continuous updates regarding the settlement can be found by visiting the official settlement website.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.